DD
Daniel Dugan
Bioinformatician at Genomenon,
View Daniel's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Bioinformatician
May 2017 - Present · 7 years and 7 months
Software Engineer
Jul 2016 - May 2017 · 10 months
Enterprise Business Development Manager
Sep 2014 - Jul 2016 · 1 years and 10 months
Company Details
51-200 Employees
Genomenon is a leading genomic intelligence company dedicated to improving the quality of patients’ lives by uncovering the genomic drivers of genetic disease and cancer. Blending the power of AI with genomic expertise, Genomenon simplifies complex genetic data into actionable insights for patient diagnosis and precision medicine development. The company’s solutions include software, data, and services. Genomenon offers advanced genomic software solutions designed to streamline and enhance genetic research and clinical decision-making. Our flagship product, the Mastermind® Genomic Intelligence Platform, provides comprehensive genomic data integration and analysis, offering researchers and clinicians a powerful tool to interpret genetic variants and their clinical relevance. Complementing this is the Clinical Knowledgebase (CKB), which focuses specifically on the landscape of somatic mutations, offering curated, actionable insights to support oncology research and personalized cancer treatment. Together, these platforms aim to accelerate discoveries and improve patient outcomes through sophisticated data analysis and knowledge integration.
Year Founded
2014
Social Media
LinkedinFacebookTwitter
Industry
Biotechnology Research
HQ Location
206 E Huron St 114 Ann Arbor, Michigan 48104, US
Keywords
BioinformaticsGenomicsWhole Exome SequencingWhole Genome SequencingGeneticsOncologyNext Generation SequencingDNAClinical ResearchPharm
Discover More About Cleveland Clinic

Find verified contacts of Daniel Dugan in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.